Avitene
Postoperative Complications
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
8 Active assets in the Postoperative Complications cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Calcium folinate pentahydrate China Meitan General Hospital | Phase 4 | BB |
FLUOROURACILUM China Meitan General Hospital | Phase 4 | BB |
Dc-Cik China Meitan General Hospital | Phase 4 | BB |
Eloxatin China Meitan General Hospital | Phase 4 | BB |
DEXAMETHASONE Rigshospitalet, Denmark | Phase 4 | BB |
View all 18 →
Same molecule, other indications
Avitene is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →